|
Volumn 92, Issue 20, 2000, Pages 1630-1632
|
After 40 years, mammography remains as much emotion as science.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADULT;
AGE;
ARTICLE;
BREAST TUMOR;
CANADA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
ECONOMICS;
FEMALE;
HEALTH CARE ORGANIZATION;
HUMAN;
MAMMOGRAPHY;
MASS SCREENING;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
PALPATION;
RADIOGRAPHY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
UNITED STATES;
ADULT;
AGE FACTORS;
BREAST NEOPLASMS;
CANADA;
COST-BENEFIT ANALYSIS;
FEMALE;
HUMANS;
MAMMOGRAPHY;
MASS SCREENING;
MIDDLE AGED;
MULTICENTER STUDIES;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PALPATION;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
SURVIVAL ANALYSIS;
UNITED STATES;
MLCS;
MLOWN;
|
EID: 0034684090
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/92.20.1630 Document Type: Article |
Times cited : (5)
|
References (0)
|